about
A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination.Recent advancement in flavivirus vaccine development.Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccineMonkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protectionThe Vaccinia Virus H3 Envelope Protein, a Major Target of Neutralizing Antibodies, Exhibits a Glycosyltransferase Fold and Binds UDP-GlucoseAn extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling.Alternative Routes of Zoonotic Vaccinia Virus Transmission, Brazil.
P2860
Q33401609-4D6AC11F-A54F-4394-A3F5-B1ED7E3A76FDQ35728621-2D294C88-8706-47BC-ADF6-2A02F21AEB3BQ36090390-470A65F0-8CAC-4F3D-AC0B-BEB56C0D6E88Q36313439-80F7A61B-778F-43DE-8289-5613A97FD226Q36878858-7D7633EF-4D9D-40D7-9519-7A2993888A23Q39764626-282A3B7C-4B96-4223-A9F9-09D0E54EE5D8Q43140302-09039E67-D54A-426F-89B8-AE0023151986
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Smallpox: residual antibody after vaccination.
@en
Smallpox: residual antibody after vaccination.
@nl
type
label
Smallpox: residual antibody after vaccination.
@en
Smallpox: residual antibody after vaccination.
@nl
prefLabel
Smallpox: residual antibody after vaccination.
@en
Smallpox: residual antibody after vaccination.
@nl
P2093
P2860
P1476
Smallpox: residual antibody after vaccination.
@en
P2093
Jeffrey E Galpin
Richard L Heberling
S S Kalter
Stephanie Gallwitz
Ted Schutzbank
P2860
P304
P356
10.1128/JCM.41.9.4068-4070.2003
P407
P577
2003-09-01T00:00:00Z